GLP-1/GIP Clinical Trial Weight Loss Results Across multiple trials, GLP-1/GIP injections consistently led to substantial weight reduction, in the range of 15-26% depending on the dosage and trial conditions
Moreover, certain assessments are limited by data availability, such as evaluations of CKD progress by measures of blood pressure, as these data are not widely available or reliable in real-world sources
To view or add a comment, sign in Considering a career in mental health
It is not a facelift, but there is a glow. This is essentially hydration returning to the cells
James van Geelen of Citrinitas Capital recently compared the obesity epidemic to the COVID crisis on Bloomberg's "Odd Lots" podcast and discussed how to make weight-loss drugs more readily available
Avoiding caffeine and alcohol on the day of treatment can enhance the effectiveness of the infusion